Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
SMOF-018-CP3: A Prospective, Randomized, Controlled, Double-Blind, Parallel-Group, Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants Requiring 28 Days of Parent
Robinson MD MSc, Daniel T
(PD/PI)
Pediatrics
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
4/1/16
→
8/31/50
Funding
Fresenius Kabi Deutschland GmbH
View all
View less